Previous close | 20.71 |
Open | 20.80 |
Bid | 20.20 x 2900 |
Ask | 20.89 x 3200 |
Day's range | 20.70 - 21.12 |
52-week range | 16.63 - 25.25 |
Volume | |
Avg. volume | 8,091,203 |
Market cap | 14.103B |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | 38.61 |
EPS (TTM) | 0.54 |
Earnings date | 01 Feb 2024 - 05 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 22.60 |
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries received a score of 100 on the Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index (CEI) and was recognized as an Equality 100 Award: Leader in LGBTQ+ Workplace Inclusion honoree. The CEI is a national benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that the company will host an Investor Day on December 8, 2023, at 9:00 a.m. Eastern Standard Time and concluding at approximately 12:00 p.m.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that President and CEO Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, Florida on Tuesday, November 28, at 10:00 a.m. Eastern Standard Time.